UBESLO
关于老挝商标「UBESLO」,老商通整理了如下公开信息,由 NewAmsterdam Pharma B.V. 于 2024-08-30 提交申请,当前状态为已注册。标识字段包括:申请号 M/1813742;注册/授权号 64883;DIP 编号 LAM1813742;主管局代码 LA;申请类型 Other。时间线要点:公开/公告日 2024-10-24;注册日 2025-07-24。分类信息显示为第 5 类。商品与服务说明摘录:Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmac…。代理机构 / 代理人记载为 NLO Shieldmark B.V.。您可在站内继续浏览同申请人其它知识产权,或经企业详情查看更多关联资产与登记信息。
The following summary describes a Laos trademark titled “UBESLO”, filed by NewAmsterdam Pharma B.V. on 2024-08-30; current status: Registered. Identifiers include application No. M/1813742; registration/grant No. 64883; DIP id LAM1813742; application type Other. Key dates: publication 2024-10-24; registration 2025-07-24. Nice class(es): 5. Goods/services excerpt: Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmac…. Use LaoBiz to hop between this IP record, related filings by the same applicant, and the matched company profile when present.
ໜ້ານີ້ສະຫຼຸບ ເຄື່ອງໝາຍການຄ້າ «UBESLO» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ NewAmsterdam Pharma B.V. ໃນວັນທີ 2024-08-30; ສະຖານະ ຈົດທະບຽນແລ້ວ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ M/1813742; ເລກທະບຽນ 64883; ລະຫັດ DIP LAM1813742. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2024-10-24; ວັນຈົດທະບຽນ/ອະນຸຍາດ 2025-07-24. ປະເພດ/ຫ້ອງ: 5. ສິນຄ້າ/ບໍລິການ: Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmac…. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
M/1813742
图样
基础信息
- 类型
- 商标
- 申请号
M/1813742- 状态
- 已注册
- 申请人
- NewAmsterdam Pharma B.V.
- 代理机构
- NLO Shieldmark B.V.
- 申请日期
- 2024-08-30
- 注册号
64883- 公开/公告日
- 2024-10-24
- 注册/授权日
- 2025-07-24
- 国际分类
- 5
- 商品 / 服务
- [5] Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, lewy body dementia, and alzheimer's disease.
办理流程
根据当前状态动态标注-
提交申请
-
形式审查
-
实质审查
-
公告
-
注册